Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00985140 · ClinicalTrials.gov registry record
Phase 2 Total Skin Electron Beam Therapy (TSEBT 12 Gy) in Stage IB-IIIA Mycosis Fungoides
A clinical trial, sponsored by Stanford University.
- Terminated
- Registry status
- 13
- Enrollment target
NCT00985140: Clinical Trial study, sponsored by Stanford University.
NCT00985140 is a clinical trial that was terminated before completion, run by Stanford University. The registered enrollment target is 13 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00985140 was terminated before completion, sponsored by Stanford University.
- TERMINATED
- Registry status
- 13 participants
- Enrollment target
Study Summary
To examine the efficacy and safety of total skin electron beam therapy to a dose of 12 Gray (TSEBT 12 Gy) in patients who have mycosis fungoides (MF) staged as IB to IIIA.
Interventions
- RADIATION Total Skin Electron Beam Therapy (TSEBT)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2009-06 |
| Est. Completion | 2012-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00985140
The ClinicalTrials.gov registry entry for NCT00985140 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Total Skin Electron Beam Therapy (TSEBT) is the first listed.
NCT00985140 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00985140 about?
NCT00985140 is a clinical study titled "Phase 2 Total Skin Electron Beam Therapy (TSEBT 12 Gy) in Stage IB-IIIA Mycosis Fungoides". To examine the efficacy and safety of total skin electron beam therapy to a dose of 12 Gray (TSEBT 12 Gy) in patients who have mycosis fungoides (MF) staged as IB to IIIA.
What is the current status of trial NCT00985140?
This trial is currently terminated. The enrollment target is 13 participants. The study started on 2009-06. Estimated completion is 2012-05.
What interventions are being tested in trial NCT00985140?
The interventions under investigation include: Total Skin Electron Beam Therapy (TSEBT) (RADIATION).
Who is sponsoring clinical trial NCT00985140?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.